AP2012006117A0 - Pharmaceutical composition of rifampicin. - Google Patents
Pharmaceutical composition of rifampicin.Info
- Publication number
- AP2012006117A0 AP2012006117A0 AP2012006117A AP2012006117A AP2012006117A0 AP 2012006117 A0 AP2012006117 A0 AP 2012006117A0 AP 2012006117 A AP2012006117 A AP 2012006117A AP 2012006117 A AP2012006117 A AP 2012006117A AP 2012006117 A0 AP2012006117 A0 AP 2012006117A0
- Authority
- AP
- ARIPO
- Prior art keywords
- rifampicin
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 title 1
- 229960001225 rifampicin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1698MU2009 | 2009-07-23 | ||
PCT/IB2010/001777 WO2011010214A1 (en) | 2009-07-23 | 2010-07-22 | Pharmaceutical composition of rifampicin |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2012006117A0 true AP2012006117A0 (en) | 2012-02-29 |
Family
ID=43498820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2012006117A AP2012006117A0 (en) | 2009-07-23 | 2010-07-22 | Pharmaceutical composition of rifampicin. |
Country Status (4)
Country | Link |
---|---|
AP (1) | AP2012006117A0 (en) |
RU (1) | RU2012104843A (en) |
WO (1) | WO2011010214A1 (en) |
ZA (1) | ZA201200531B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3047325A1 (en) * | 2016-12-21 | 2018-06-28 | Tioga Pharmaceuticals Inc. | Solid pharmaceutical formulations of asimadoline |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0650728B1 (en) * | 1993-10-29 | 2002-02-27 | Council of Scientific and Industrial Research | Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug |
US5744161A (en) * | 1995-02-24 | 1998-04-28 | Sabinsa Corporation | Use of piperine as a bioavailability enhancer |
IN186315B (en) * | 1996-12-12 | 2001-08-04 | Panacea Biotec Ltd | |
MXPA02003596A (en) * | 2000-08-09 | 2003-10-14 | Panacea Biotec Ltd | Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation. |
EP1494749B1 (en) * | 2002-04-04 | 2006-11-08 | Cadila Pharmaceuticals Limited | Process for preparation of pharmaceutical composition containing antiretroviral protease inhibitor with improved bioavailability |
-
2010
- 2010-07-22 AP AP2012006117A patent/AP2012006117A0/en unknown
- 2010-07-22 WO PCT/IB2010/001777 patent/WO2011010214A1/en active Application Filing
- 2010-07-22 RU RU2012104843/15A patent/RU2012104843A/en not_active Application Discontinuation
-
2012
- 2012-01-23 ZA ZA2012/00531A patent/ZA201200531B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201200531B (en) | 2012-10-31 |
RU2012104843A (en) | 2013-08-27 |
WO2011010214A1 (en) | 2011-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1231408A1 (en) | Pharmaceutical composition | |
HK1218881A1 (en) | Pharmaceutical compositions | |
EP2451274A4 (en) | Pharmaceutical compositions | |
EP2379077A4 (en) | Pharmaceutical composition | |
EP2500038A4 (en) | Pharmaceutical composition for external use | |
ZA201104670B (en) | Pharmaceutical composition comprising aleglitazar | |
IL211062A0 (en) | Pharmaceutical uses of lanosta-8,24-dien-3-ols | |
ZA201200659B (en) | Pharmaceutical composition of isoniazid | |
IL219018A0 (en) | Pharmaceutical compositions | |
GB0919650D0 (en) | Pharmaceutical composition | |
GB0917775D0 (en) | Novel pharmaceutical compounds | |
AP2012006117A0 (en) | Pharmaceutical composition of rifampicin. | |
GB0917774D0 (en) | Novel pharmaceutical compounds | |
HU0900010D0 (en) | Improved pharmaceutical composition | |
GB0910225D0 (en) | Pharmaceutical compositions |